FDA Investigator Elisa M Fleming

Elisa M Fleming has conducted inspections on 101 sites in 2 countries as of 19 Jan 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
101
Last Inspection Date:
19 Jan 2023
Investigator Role:
FDA Investigator
Redica ID:
100002838
Countries of Inspections:
United States of America, South Africa
FDA Investigators that have inspected at least one site in common with Elisa M Fleming:
Adam C Hipko, Adrian Rodriguez, Akbar J Zaidi, Alan P Kurtzberg, Alcee M Tavarez, Alfredo Iniguez Garcia, Amanda J White, Andrace L Deyampert, Andrea A Branche, Andrew J Lang, Andrew R Wasko, Anh M Lac, Annette Melendez, Anya Dlockett Evans, Arie R Dyk, Ashley N Williams, Benjamin K Kingsley, Betsy C Galliher, Bhanu M Kannan, Bing Lin, Blondell W Johnson, Brackens Harris, Brandi N Mcgrady, Brandon K Barbee, Camille D Brown, Casey L Hamblin, Cathleen A Castellaw, Chad J Whitwell, Charles D Brown, Charles L Larson, Christopher D Rush, Christopher J Hurst, Christopher J Smith, Christopher K Gibbs, Christopher L Jacobs, Connie L Hannon Rabel, Constance M Dobbins, Corrine M Carter, Cymbre Weatherly, Cynthia A Harris, MD, RN, Dallas E Gilbreath Jr, Dana M Lewis, Daniel J Lahar, Daniel S Fam, Danielle Lyke, Danny D Horner, David M Beltran, David W Pitman, Dawn C Olenjack, Decarlos A Gomez, Denise Connelly, Deniza Karacic, Dirk L Lincoln, Don A Leeseberg, Dr. Jason R Caballero, Elizabeth D Connell, Elmina E Akwo, Elmina E Mboh, Elvia J Cervantes, Fernando C Martinez, Frans E Mercado, Gilbert Valdez, RS, Glasgow Glasgow, Grant L Davis, Gwendolyn F Anderson, Haley L Coleman, Ifueko Osemwota, Iris C Macinnes, J Elkins, Jacey Roy, Jacob W Reynolds, James H Robinson, Jamie M Bumpas, Jane M Broussard, Janice M Hickok, Jeffrey R Wooley, Jennifer D Young, Jennifer Hua, Jennifer O Dowdy, Jessica M Simpson, PhD, Joanne M Schlossin, Jodi M Gatica, Joel D Martinez, Johann M Fitch, Johnson, Jonathan A Womack, Jonathan M Mcbride, Jose Martinez, Jr, Joshua J Silvestri, Joy L Ramsey, Jude C Dikes, Kamara Tx, Karen C Daugherty, Karlton T Watson, Kathleen Chmura Shaffer, Kayla R Deatherage, Kelly J Pegg, Kelly N Kerr, Kenitra D Hewitt, L Grant, Latorie S Jones, Lauren E Skokan, Lauren M Lilly, PhD, Lauren R Brady, Lawrence C Coleman, Lawrence C Prine, Leighton Kn Gai, Lesley Maep Lutao, Lewis K Antwi, Lisa M Puttonen, Lisa R Jennings, Lisa R Whitt, Liza L Quiles, Lloyd D Payne, Lorie S Hannappel, Lourdes R Genera, Maira P Brading, Marc R Dickens, Margaret M Annes, Margaret Torres Vazquez, Maria Elenagamble Rs, Marilyn S Babu, Martha S Baldwin, Matthew R Maddox, Michael L Jones, Michelle A Krayer, Micmarie Ramos Rodriguez, Monique Rac Lester, Monique S Frazier, Nimmy Mathews, Ninfa N Innocent, Patrice S Hall, Patrick D Stone, MS, Patty P Kaewussdangkul, Paul E Frazier, Pauline N Logan, Payne, Perla M Castillo, Philip M Steele, PhD, Phillip D Waldron, Phillip J Sample, Quynh Anh H Tran, Rebecca Co Bryan, Rendall E Barfoot, Rhonda L Dash, Rian L Pope, Richard T Riggie, Robert T Lorenz, Ronda Rloyd Jones, Roy Baby, Saijal P Naik, Samuel A Hamblin, Sandy J Ziegler, Sarah L Fredric, Scott R Nichols, PhD, Scott T Ballard, Sean M Cheney, Selina M Mata, Seri L Essary, Shanna N Purdy, Shannon A Lowe, Shawn E Larson, Shelby N Turner, Sherrie L Krolczyk, Staci G Mcallister, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Stephen L Beekman, Suzie L Kent, Tamera H Hunt, Tara A Gray, Tara K Carmody, Tara K Normandin, Terri E Gibson, Timothy B Webb, Toby Vern H Hill, Tracy J Washington, Travis M Beard, Travis S Brown, Tricia S Martinez, Trina K Vick, Verlinda A Narcisse, Vivian Garcia, Yaw O Osei, Young M Yoon, Zerita White

Elisa M Fleming's Documents

Publish Date Document Type Title
February, 2014 FDA 483 Stanley E. Grogg, DO - Form 483, 2014-02-10
September, 2012 FDA 483 Response Texas Biomedical Research Institute - Form 483R, 2012-10-09
October, 2012 FDA 483 Pablo J. Sanchez, M.D. - Form 483, 2012-10-22
February, 2014 FDA 483 Response Stanley E. Grogg, DO - Form 483R, 2014-02-24
August, 2012 EIR Richard L. Wasserman, M.D. - EIR, 2012-08-17
December, 2012 EIR Univar Solutions USA Inc. - EIR, 2012-12-20
February, 2015 FDA 483 Chemolee Lab Corporation - Form 483, 2015-02-13
January, 2013 EIR Tomasovic, Jerry, M.D. - EIR, 2013-01-18
December, 2011 FDA 483 Suzanne K. Gazda, M.D. - Form 483, 2011-12-08
September, 2012 EIR Texas Biomedical Research Institute - EIR, 2012-09-19
January, 2023 FDA 483 Reproductive Services Of Indiana, Inc - Form 483, 2023-01-20
May, 2011 FDA 483 Mahard Egg Farms, Inc - Form 483, 2011-05-24
April, 2015 FDA 483 Dr. Peter Szmuk - Form 483, 2015-04-17
September, 2012 FDA 483 Texas Biomedical Research Institute - Form 483, 2012-09-19
April, 2013 FDA 483 Response Mother Frances Hospital IRB - Form 483R, 2013-04-15
January, 2013 FDA 483 Tomasovic, Jerry, M.D. - Form 483, 2013-01-18
May, 2009 FDA 483 ARG LABORATORIES INC - Form 483, 2009-06-10
March, 2012 FDA 483 Colgate Oral Pharmaceuticals, Inc. - Form 483, 2012-03-09
December, 2013 FDA 483 Abrams Royal Pharmacy - Form 483, 2013-12-20
February, 2014 EIR Stanley E. Grogg, DO - EIR, 2014-02-10
November, 2013 FDA 483 USPlabs, LLC - Form 483, 2013-11-05
April, 2013 FDA 483 Mother Frances Hospital IRB - Form 483, 2013-04-02
April, 2013 EIR Mother Frances Hospital IRB - EIR, 2013-04-02
April, 2012 EIR Galderma Laboratories, L.P. - EIR, 2012-04-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more